Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroma, Acoustic × icotinib × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 7 Brain Neoplasms 7 Neuroma, Acoustic 1 Neurofibromatosis 2 1 Neoplasm Metastasis 1 Lung Neoplasms 1

Interventions

Radiosurgery 6 Cochlear Implants 4 Bevacizumab 4 Gentamicins 3 Everolimus 3 Lapatinib 2 tozuleristide 1 neratinib 1 icotinib 1 gallium Ga 68 dotatate 1 brigatinib 1 Triamcinolone Acetonide 1 Temozolomide 1 Sufentanil 1 Sirolimus 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Mn-PyC3A 1 Microsurgery 1 Methylprednisolone 1 Magnetic Resonance Spectroscopy 1 Fluoresceins 1 Fluorescein 1 Exome 1 Endostatins 1 Endoscopes 1 Docosahexaenoic Acids 1 Decision Support Techniques 1 Axitinib 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02934256 2021-09-09

Icotinib

Beijing Tiantan Hospital

Phase 2 Completed

Neuroma, Acoustic, Neurofibromatosis 2

Data powered by HemOnc (CC BY 4.0) Colophon ⚡